they should not be interpreted as established clinical outcomes, and no head-to-head comparative data with other agents currently exist
Lifestyle factors, such as regular physical activity and stress management, can significantly enhance the body's natural GLP-1 response
one 68-week, randomized, double-blind, placebo withdrawal trial
Two studies were carried out in healthy subjects to investigate the effects of semaglutide on the pharmacokinetics of four therapies that are commonly co-administered with GLP-1RAs [14,15,16] and are characterised by differing properties of solubility and intestinal permeability [17]
Conducting well-designed clinical trials specifically focused on the use of DPP-IV inhibitors in PTC is imperative
Humana Press, New York, NY